AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 159 filers reported holding AKERO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,774,131 | +15.7% | 252,553 | +6.8% | 0.00% | 0.0% |
| Q2 2023 | $11,039,804 | +1446.9% | 236,449 | +1167.6% | 0.00% | – |
| Q1 2023 | $713,664 | -93.6% | 18,653 | -90.8% | 0.00% | -100.0% |
| Q4 2022 | $11,125,934 | +37.4% | 203,028 | -14.7% | 0.00% | 0.0% |
| Q3 2022 | $8,100,000 | +5300.0% | 237,886 | +2147.4% | 0.00% | – |
| Q1 2022 | $150,000 | -32.1% | 10,585 | +1.5% | 0.00% | – |
| Q4 2021 | $221,000 | -15.0% | 10,429 | -10.5% | 0.00% | – |
| Q3 2021 | $260,000 | +4.4% | 11,656 | +16.2% | 0.00% | – |
| Q2 2021 | $249,000 | – | 10,029 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 1,621,829 | $75,723,196 | 32.88% |
| COMMODORE CAPITAL LP | 1,675,000 | $78,205,750 | 8.79% |
| Ghost Tree Capital, LLC | 360,000 | $16,808,400 | 5.55% |
| Boxer Capital, LLC | 1,676,733 | $78,287 | 3.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 241,357 | $11,268,958 | 3.49% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $27,745,579 | 3.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 236,500 | $11,039,820 | 3.42% |
| Logos Global Management LP | 520,000 | $24,278,800 | 3.30% |
| Redmile Group, LLC | 1,811,672 | $84,586,966 | 3.25% |
| Yiheng Capital Management, L.P. | 1,201,591 | $56,102,284 | 3.03% |